HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
V Pérez Selected Research
V Pérez Research Topics
Disease
4
Inflammation (Inflammations)
05/2014 - 07/2009
3
Visna
02/2015 - 02/2006
3
Neoplasms (Cancer)
02/2015 - 12/2001
3
Proteinuria
10/2010 - 07/2009
2
Necrosis
11/2013 - 09/2005
2
Psychotic Disorders (Schizoaffective Disorder)
05/2008 - 12/2006
2
Parkinson Disease (Parkinson's Disease)
01/2000 - 01/2000
1
Retinoblastoma (Glioblastoma, Retinal)
06/2021
1
Pain (Aches)
01/2021
1
Pulmonary Hypertension
06/2018
1
Border Disease
02/2017
1
Cicatrix (Scar)
09/2015
1
Autoimmune Diseases (Autoimmune Disease)
08/2015
1
Bipolar Disorder (Manic Depressive Psychosis)
08/2015
1
of Sheep Progressive Interstitial Pneumonia (Maedi)
02/2015
1
Disease Progression
02/2015
1
Major Depressive Disorder (Major Depressive Disorders)
05/2014
1
Granuloma
11/2013
1
Anorexia
11/2013
1
Tuberculosis (Tuberculoses)
11/2013
1
Diarrhea
11/2013
1
Secondary Hyperparathyroidism
10/2010
1
Acidosis
06/2010
1
Dyskinesias (Dyskinesia)
10/2009
1
Arteriosclerosis
07/2009
1
Cardiovascular Diseases (Cardiovascular Disease)
07/2009
1
Diabetes Mellitus
07/2009
1
Chronic Kidney Failure (Chronic Renal Failure)
07/2009
1
Dyslipidemias (Dyslipidemia)
07/2009
1
Renal Insufficiency (Renal Failure)
07/2009
1
Scrapie
08/2008
1
Schizophrenia (Dementia Praecox)
12/2006
1
Mania (Manias)
12/2006
1
Borderline Personality Disorder (Personality Disorders, Borderline)
05/2006
1
Latent Infection
09/2005
1
Rheumatoid Arthritis
09/2005
1
Crohn Disease (Crohn's Disease)
08/2005
1
Secretory breast carcinoma
06/2005
1
Cachexia
04/2005
1
Hemolytic Anemia
04/2005
1
Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2003
1
Carcinoma (Carcinomatosis)
12/2001
1
Aortic Dissection
01/2001
Drug/Important Bio-Agent (IBA)
3
Peptides (Polypeptides)
IBA
03/2012 - 07/2009
2
Antibodies
IBA
08/2015 - 03/2012
2
Acids
IBA
11/2013 - 08/2005
2
Olanzapine (Zyprexa)
FDA Link
05/2008 - 12/2006
1
Topotecan (Hycamtin)
FDA Link
Generic
06/2021
1
Melphalan (Alkeran)
FDA Link
Generic
06/2021
1
RNA (Ribonucleic Acid)
IBA
02/2017
1
Muramidase (Lysozyme)
IBA
09/2015
1
Biological Products
IBA
08/2015
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
08/2015
1
Cytosine
IBA
02/2015
1
Glial Fibrillary Acidic Protein
IBA
05/2014
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2013
1
Antiparasitic Agents (Antiparasitics)
IBA
11/2013
1
Immunodominant Epitopes
IBA
03/2012
1
paricalcitol (Zemplar)
FDA Link
10/2010
1
Calcitriol Receptors (Calcitriol Receptor)
IBA
10/2010
1
Minerals
IBA
10/2010
1
Parathyroid Hormone (Parathormone)
IBA
10/2010
1
Antioxidants
IBA
06/2010
1
naringin
IBA
06/2010
1
Thiobarbituric Acid Reactive Substances
IBA
06/2010
1
Flavonoids
IBA
06/2010
1
Levodopa (L Dopa)
FDA Link
Generic
10/2009
1
beta 2-Glycoprotein I (Apolipoprotein H)
IBA
07/2009
1
trans-crotonin (CTN)
IBA
07/2009
1
Atorvastatin (Lipitor)
FDA Link
07/2009
1
Autoantibodies
IBA
07/2009
1
C-Reactive Protein
IBA
07/2009
1
Cholesterol
IBA
07/2009
1
Creatinine
IBA
07/2009
1
Pharmaceutical Preparations
IBA
07/2009
1
Immunoglobulin A (IgA)
IBA
07/2009
1
Lipids
IBA
07/2009
1
Triglycerides (Triacylglycerol)
IBA
07/2009
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
07/2009
1
Prion Proteins
IBA
08/2008
1
Antipsychotic Agents (Antipsychotics)
IBA
05/2006
1
Paraffin
IBA
02/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2005
1
Infliximab (Remicade)
FDA Link
09/2005
1
Viral DNA
IBA
09/2005
1
Hemosiderin
IBA
04/2005
1
DNA (Deoxyribonucleic Acid)
IBA
12/2001
1
Cyclin E
IBA
12/2001
1
S 23906-1
IBA
12/2001
1
Acronine (Acronycine)
IBA
12/2001
1
Copper
IBA
01/2001
Therapy/Procedure
3
Therapeutics
01/2021 - 02/2000
2
Kidney Transplantation
10/2010 - 07/2009
1
Drug Therapy (Chemotherapy)
06/2021
1
Lung Transplantation
06/2018
1
Salvage Therapy
02/2015
1
Deep Brain Stimulation
05/2014
1
Injections
05/2006
1
Modified Radical Mastectomy (Mastectomy, Modified)
06/2005
1
Transcranial Magnetic Stimulation
01/2003